Search references for SELONABANT. Phrases containing SELONABANT
See searches and references containing SELONABANT!SELONABANT
Pharmaceutical compound
Selonabant (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name; developmental code names ANEB-001, V-24343) is a cannabinoid
Selonabant
Medication for pain and fever
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Paracetamol
Genus of flowering plants
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabis
Phytocannabinoid discovered in 1940
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabidiol
Species of plant
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Kava
Psychoactive component of cannabis
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Tetrahydrocannabinol
Psychoactive drug from the cannabis plant
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabis_(drug)
Drug that blocks hallucinogen effects
CB1 receptor antagonists like rimonabant, drinabant, surinabant, and selonabant have been found to block or reduce the psychoactive effects of cannabinoids
Trip_killer
Designer drug
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
ADMB-3TMS-PRINACA
Cannabis sativa L. (marijuana; hemp) used medicinally
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Medical_cannabis
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
4'Cl-CUMYL-PINACA
Species of plant
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabis_indica
Species of plant
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabis_ruderalis
Plant species
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabis_sativa
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Rimonabant
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Honokiol
Chemical compound (fatty acid neurotransmitter)
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Anandamide
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Palmitoylethanolamide
Group of receptors to cannabinoid compounds
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoid_receptor
Biological system of neurotransmitters
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Endocannabinoid_system
Specific cannabis extract
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Nabiximols
Homologue of tetrahydrocannabinol
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Tetrahydrocannabivarin
Synthetic cannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Nabilone
Drug designed to treat obesity
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Orlistat
Naturally-occurring cannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JWH-018
Minor cannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabigerol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Pregnenolone
Active metabolite of paracetamol
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
AM404
Medication and supplement
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Pregnenolone_(medication)
Mammalian protein found in humans
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoid_receptor_1
Designer drugs
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Synthetic_cannabinoids
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
AM-2201
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Monlunabant
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Zevaquenabant
Compounds found in cannabis
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoid
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Kaempferol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Genistein
Mammalian protein found in Homo sapiens
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoid_receptor_2
Proposed mechanism of cannabis compounds
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Entourage_effect
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Falcarinol
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
ONO-1110
Natural bicyclic sesquiterpene
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Caryophyllene
Mammalian protein found in Homo sapiens
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Fatty-acid_amide_hydrolase_1
Active metabolite of Δ9-THC
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
11-Hydroxy-THC
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
WIN_55,212-2
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JNJ-42165279
Investigational substance-related disorder drugs
serotonin 5-HT2A receptor agonist, and serotonergic psychedelic – alcoholism Selonabant (ANEB-001; V-24343) – cannabinoid CB1 receptor antagonist – substance-related
List of investigational substance-related disorder drugs
List_of_investigational_substance-related_disorder_drugs
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Epicatechin_gallate
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
MDMB-4en-PINACA
Main secondary metabolite of THC
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
11-Nor-9-carboxy-THC
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
List_of_cannabinoids
Synthetic cannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
HU-210
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JWH-073
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Gallocatechol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Ibipinabant
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Oleoylethanolamide
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Yangonin
Class of enzymes
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Monoacylglycerol_lipase
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
ADB-5'Br-BUTINACA
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Dimethylheptylpyran
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JD5037
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
AB-CHMINACA
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
MDMB-FUBINACA
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JWH-007
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Levonantradol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
PX-3
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Oleamide
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Irafamdastat
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
NNE1
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
WOBE437
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Dronabinol/palmidrol
Working on the endocannabinoid neurotransmitters
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoidergic
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
SYT-510
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
N-Arachidonoyl_dopamine
Synthetic homologue of THC
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Parahexyl
Class of drugs
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Endocannabinoid reuptake inhibitor
Endocannabinoid_reuptake_inhibitor
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
2-Arachidonoylglycerol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
JWH-133
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
SDB-005
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Stearoylethanolamide
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Lysophosphatidylinositol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
MDMB-CHMICA
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Endocannabinoid_transporter
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Arachidonoyl_serotonin
Protein-coding gene in the species Homo sapiens
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
GPR55
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
5F-CUMYL-PINACA
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Magnolol
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Z8526711350
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Biochanin_A
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
AM-251_(drug)
Synthetic cannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
THJ-2201
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
CP_55,940
Phytocannabinoid
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabidiorcol
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
N-Arachidonylglycine
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
BIA_10-2474
Compounds that inhibit or block the activity of cannabinoid receptors
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Cannabinoid receptor antagonist
Cannabinoid_receptor_antagonist
Chemical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
Drinabant
Pharmaceutical compound
LY-320,135 MK-9470 NESS-0327 O-2050 Otenabant PF-514273 PipISB Rosonabant Selonabant THCV VCHSR Virodhamine CB2Tooltip Cannabinoid receptor 2 Agonists 2-AG
ZYN-001
SELONABANT
SELONABANT
SELONABANT
SELONABANT
SELONABANT
SELONABANT
SELONABANT
SELONABANT
SELONABANT